drugset / Trial / NCT03845348
To Evaluate the Efficacy and Safety of Shampoo TD03 and TD07 in Scalp Diseases
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Scalp Conditions are common chronic skin inflamations with the occurence rate of 1 - 5 % among the population. TD03 shampoo and TD07 shampoo are widely used to avoid hair loss with successful rate reaching nearly 95%. This trial is going to evaluate the efficacy of getting rid of dandruff as well as the safety of the investigational products in comparison to a reference (ketoconazole 2%) during a 4-week treatment period.
Timeline
- Start
- 2019-05-22
- Primary completion
- 2022-12
- Completion
- 2023-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ketoconazole | Small molecule | 2 % | Topical |